Literature DB >> 29610268

Diabetes Mellitus in Pregnancy Leads to Growth Restriction and Epigenetic Modification of the Srebf2 Gene in Rat Fetuses.

Michaela Golic1, Violeta Stojanovska1, Ivo Bendix1, Anika Wehner1, Florian Herse1, Nadine Haase1, Kristin Kräker1, Caroline Fischer1, Natalia Alenina1, Michael Bader1, Till Schütte1, Mirjam Schuchardt1, Markus van der Giet1, Wolfgang Henrich1, Dominik N Muller1, Ursula Felderhoff-Müser1, Sicco Scherjon1, Torsten Plösch1, Ralf Dechend2.   

Abstract

Diabetic pregnancy is correlated with increased risk of metabolic and neurological disorders in the offspring putatively mediated epigenetically. Little is known about epigenetic changes already present in fetuses of diabetic pregnancies. We aimed at characterizing the perinatal environment after preexisting maternal diabetes mellitus and at identifying relevant epigenetic changes in the fetus. We focused on the transcription factor Srebf2 (sterol regulatory element binding transcription factor 2), a master gene in regulation of cholesterol metabolism. We tested whether diabetic pregnancy induces epigenetic changes in the Srebf2 promoter and if they become manifest in altered Srebf2 gene expression. We worked with a transgenic rat model of type 2 diabetes mellitus (Tet29) in which the insulin receptor is knocked down by doxycycline-induced RNA interference. Doxycycline was administered preconceptionally to Tet29 and wild-type control rats. Only Tet29 doxycycline dams were hyperglycemic, hyperinsulinemic, and hyperlipidemic. Gene expression was analyzed with quantitative real-time reverse transcriptase polymerase chain reaction and CpG promoter methylation with pyrosequencing. Immunohistochemistry was performed on fetal brains. Fetuses from diabetic Tet29 dams were hyperglycemic and growth restricted at the end of pregnancy. They further displayed decreased liver and brain weight with concomitant decreased microglial activation in the hippocampus in comparison to fetuses of normoglycemic mothers. Importantly, diabetic pregnancy induced CpG hypermethylation of the Srebf2 promoter in the fetal liver and brain, which was associated with decreased Srebf2 gene expression. In conclusion, diabetic and hyperlipidemic pregnancy induces neurological, metabolic, and epigenetic alterations in the rat fetus. Srebf2 is a potential candidate mediating intrauterine environment-driven epigenetic changes and later diabetic offspring health.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  Srebf2; diabetes mellitus; epigenetics; fetal programming; hyperlipidemia; pregnancy; rat

Mesh:

Substances:

Year:  2018        PMID: 29610268     DOI: 10.1161/HYPERTENSIONAHA.117.10782

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  5 in total

1.  RNA interference therapeutics targeting angiotensinogen ameliorate preeclamptic phenotype in rodent models.

Authors:  Nadine Haase; Donald J Foster; Mark W Cunningham; Julia Bercher; Tuyen Nguyen; Svetlana Shulga-Morskaya; Stuart Milstein; Sarfraz Shaikh; Jeff Rollins; Michaela Golic; Florian Herse; Kristin Kräker; Ivo Bendix; Meray Serdar; Hanna Napieczynska; Arnd Heuser; Alexandra Gellhaus; Kristin Thiele; Gerd Wallukat; Dominik N Müller; Babbette LaMarca; Ralf Dechend
Journal:  J Clin Invest       Date:  2020-06-01       Impact factor: 14.808

Review 2.  Adverse neuropsychiatric development following perinatal brain injury: from a preclinical perspective.

Authors:  Ivo Bendix; Martin Hadamitzky; Josephine Herz; Ursula Felderhoff-Müser
Journal:  Pediatr Res       Date:  2018-10-26       Impact factor: 3.756

Review 3.  Low Birthweight as a Risk Factor for Non-communicable Diseases in Adults.

Authors:  Maria Eugenia Bianchi; Jaime M Restrepo
Journal:  Front Med (Lausanne)       Date:  2022-01-06

4.  Diabetic pregnancy as a novel risk factor for cardiac dysfunction in the offspring-the heart as a target for fetal programming in rats.

Authors:  Till Schütte; Sarah M Kedziora; Nadine Haase; Florian Herse; Natalia Alenina; Dominik N Müller; Michael Bader; Michael Schupp; Ralf Dechend; Michaela Golic; Kristin Kräker
Journal:  Diabetologia       Date:  2021-09-18       Impact factor: 10.122

5.  Continuous Blood Glucose Monitoring Reveals Enormous Circadian Variations in Pregnant Diabetic Rats.

Authors:  Michaela Golic; Kristin Kräker; Caroline Fischer; Natalia Alenina; Nadine Haase; Florian Herse; Till Schütte; Wolfgang Henrich; Dominik N Müller; Andreas Busjahn; Michael Bader; Ralf Dechend
Journal:  Front Endocrinol (Lausanne)       Date:  2018-05-29       Impact factor: 5.555

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.